These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 12976791)
41. PRODUCTION AND STANDARDIZATION OF ANTISERA TO THE ECHO AND COXSACKIE GROUP B VIRUSES. HAMBLING MH; PORTER AA; DAVIS PM; MACRAE AD Mon Bull Minist Health Public Health Lab Serv; 1965 Jan; 24():15-20. PubMed ID: 14270697 [No Abstract] [Full Text] [Related]
43. [SELECTIVE ACTION ON VARIANTS OF THE COXSACKIE B 5 VIRUS BY CULTURES OF HELA CELLS]. PAULUZZI S Riv Ist Sieroter Ital; 1965; 40():82-9. PubMed ID: 14328587 [No Abstract] [Full Text] [Related]
44. HAEMAGGLUTINATION BY ENTERO-VIRUSES ISOLATED FROM CASES OF FEVER WITH OR WITHOUT NEUROLOGICAL INVOLVEMENT IN CHILDREN. BAL A; GUPTA NP; PAUL S Indian J Med Res; 1963 Sep; 51():859-64. PubMed ID: 14065208 [No Abstract] [Full Text] [Related]
45. Viral agents oncolytic for human tumors in heterologous host; oncolytic effect of Coxsackie B viruses. SUSKIND RG; HUEBNER RJ; ROWE WP; LOVE R Proc Soc Exp Biol Med; 1957 Feb; 94(2):309-18. PubMed ID: 13408245 [No Abstract] [Full Text] [Related]
46. Cytopathologic changes in tissue cultures of human amnionic cells infected with poliomyelitis, Coxsackie, and ECHO viruses. BERNKOPF H; ROSIN A Am J Pathol; 1957; 33(6):1215-27. PubMed ID: 13478665 [No Abstract] [Full Text] [Related]
47. [Symbiosis between neurotropic Coxsackie virus strain B and louping ill virus]. LEVADITI C; HENRY-EVENO J Ann Inst Pasteur (Paris); 1953 Apr; 84(4):778-80. PubMed ID: 13124978 [No Abstract] [Full Text] [Related]
48. [INHIBITORY EFFECT OF CULTURES OF HELA CELLS ON THE HEMAGGLUTINATING POWER OF THE COXSACKIE B 5 VIRUS]. PAULUZZI S Riv Ist Sieroter Ital; 1965; 40():73-81. PubMed ID: 14328586 [No Abstract] [Full Text] [Related]
49. [Determination of antibodies to Coxsackie and ECHO viruses by the color test and cytopathic action]. ZUBOVA ZF; GORDIENKO NM; BORUTSKAIA TR Vopr Virusol; 1963; 8():104-8. PubMed ID: 14004011 [No Abstract] [Full Text] [Related]
50. [ASPECTS OF THE ISOLATION OF ENTERIC VIRUSES FROM THE CEREBROSPINAL FLUID IN THE YEARS 1961-63]. CIUGARIN M; MANITIU M; ALEXANDRU M Stud Cercet Inframicrobiol; 1964; 15():543-55. PubMed ID: 14309289 [No Abstract] [Full Text] [Related]
51. MOUSE PATHOGENIC AGENTS FROM 1958 EPIDEMIC OF ENCEPHALITIS IN LUCKNOW. GUPTA U; GUPTA NP; GUPTA SP Indian J Med Res; 1964 Jun; 52():581-6. PubMed ID: 14182675 [No Abstract] [Full Text] [Related]
52. DISC METHOD FOR IDENTIFICATION AND TITRATION OF CYTOPATHIC VIRUSES AND DETECTION OF ANTIBODIES RESULTING FROM THEIR INFECTION. KALTER SS J Lab Clin Med; 1963 Sep; 62():525-34. PubMed ID: 14065301 [No Abstract] [Full Text] [Related]
53. [Characteristics of enterovirus infection in cultures of human and mouse hybrid cells]. Mustafina AN; Lashkevich VA; Koroleva GA Vopr Virusol; 1984; 29(4):476-80. PubMed ID: 6093387 [TBL] [Abstract][Full Text] [Related]
54. [Symbiosis between encephalitogenic type B Coxsackie virus and that of neurotropic foot and mouth disease]. LEVADITI C; VAISMAN A Ann Inst Pasteur (Paris); 1951 Aug; 81(2):210-3. PubMed ID: 14868872 [No Abstract] [Full Text] [Related]
55. Observations on the neutralizing antibody response to group B Coxsackie viruses in patients with central nervous system disease. LENNETTE EH; SHINOMOTO TT; SCHMIDT NJ; MAGOFFIN RL J Immunol; 1961 Mar; 86():257-66. PubMed ID: 13760856 [No Abstract] [Full Text] [Related]